ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that it is one of only three companies to receive the NorthFace ScoreBoard Award℠ for the tenth consecutive year for ‘world class’ excellence in customer satisfaction. Now in its eleventh year, the award is presented annually by Omega Management Group Corp., Billerica, Mass., to companies that, as rated solely by their own customers, achieved excellence in customer satisfaction during the prior calendar year.
“This recognition clearly demonstrates the importance we place on technical support and customer service as we develop products that help advance the practices of resuscitation and critical care,” said Jonathan A. Rennert, President of ZOLL. “It is paramount to ZOLL that our customer satisfaction levels remain high since our customers are in the business of saving lives.”
“The NorthFace ScoreBoard Award recognizes organizations that not only offer exemplary customer service, but also center their existence on a deep commitment to exceeding customer expectations,” said John Alexander Maraganis, President and CEO of Omega. “In 2010, more than 250 projects, many international in scope, were judged from 37 companies based in the U.S. and abroad. The majority of companies are repeat recipients, which shows that, despite the tough economy, implementing a customer experience management strategy is a reliable, proven way to achieve business success.”
Methodology for Measurement
Omega’s methodology measures customer satisfaction and loyalty levels on a 5-point scale four times during the year in such categories as technical support, field service, customer service, and account management. The 22 NorthFace ScoreBoard Award recipients are companies which, based solely on survey responses from their own customers, achieved a 4.0 or above out of a possible 5.0. Omega’s research shows that companies that consistently achieve a 4.0 or above succeed in establishing customer loyalty.
About ZOLL Medical Corporation
ZOLL Medical Corporation (zoll.com) develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, fluid resuscitation, and therapeutic temperature management, ZOLL provides a comprehensive set of technologies which help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and critical care.
A NASDAQ Global Select company and a Forbes 100 Most Trustworthy Company in 2007, 2008, and 2009, ZOLL develops and manufactures its products in the United States, in California, Colorado, Illinois, Massachusetts, Pennsylvania, and Rhode Island. More than 400 direct sales and service representatives, 1,100 business partners, and 200 independent representatives serve our customers in over 140 countries around the globe.
Certain statements contained in this press release, including statements regarding the future business of the Company, and other statements contained herein regarding matters that are not historical facts, are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled “Risk Factors” in the Company's Annual Report on Form 10-K filed with the SEC on December 17, 2010. You should not place undue reliance on the forward looking statements in this press release, and the Company disavows any obligation to update or supplement those statements in the event of any changes in the facts, circumstances, or expectations that underlie those statements.
Copyright © 2011 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. ZOLL is a registered trademark of ZOLL Medical Corporation in the United States and/or other countries. NorthFace ScoreBoard Award is a service mark of Omega Management Group Corporation. All product names are the property of their respective owners.
A. Ernest Whiton, Chief Financial Officer
ZOLL Medical Corporation / P: +1 (978) 421-9655